Go to the list of all blogs
Abhoy Sarkar's Avatar
published in Blogs
Sep 15, 2020

Gilead (GILD, $66.34) to acquire Immunomedics Inc for $21 billion, to strengthen cancer portfolio

Biopharmaceutical company Gilead Sciences Inc will acquire biotech company Immunomedics Inc for $21 billion. The acquisition is expected to bolster Gilead’s cancer portfolio.

Gilead’s tender offer includes buying all the outstanding shares of Immunomedics for $88 per share, which implies a premium of about 108% over their closing price on Friday.

Through the deal, Gilead will have access to Immunomedics’ breast cancer treatment drug Trodelvy, which was granted an accelerated FDA approval in April. Immunomedics is also on track to file for regulatory approval for Trodelvy in Europe in the first half of 2021.

Trodelvy targets triple-negative breast cancer that has spread to other organs. The tumor types are aggressive and tough to treat.

“This acquisition represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio,” Gilead Chief Executive Officer Daniel O’Day said in a statement. “Trodelvy is an approved, transformational medicine for a form of cancer that is particularly challenging to treat. We will now continue to explore its potential to treat many other types of cancer.”

According to Tickeron, GILD is in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2020

GILD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 43 cases where GILD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 58%.

Current price $66.34 crossed the support line at $64.63 and is trading between $66.73 support and $64.63 support lines. Throughout the month of 08/12/20 - 09/14/20, the price experienced a -3% Downtrend, while the week of 09/04/20 - 09/14/20 shows a +2% Uptrend.

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GILD's RSI Indicator exited the oversold zone, 12 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%

The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 61 cases where GILD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on September 11, 2020. You may want to consider a long position or call options on GILD as a result. In 49 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 47%.

The Moving Average Convergence Divergence (MACD) for GILD just turned positive on August 31, 2020. Looking at past instances where GILD's MACD turned positive, the stock continued to rise in 25 of 49 cases over the following month. The odds of a continued upward trend are 51%.

Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in 140 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.

Bearish Trend Analysis

The 50-day Moving Average for GILD moved below the 200-day moving average on September 10, 2020. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for GILD entered a downward trend on September 10, 2020. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Tickeron has a positive outlook on this ticker and predicts a further increase by more than 4.00% within the next month with a likelihood of 55%. During the last month, the daily ratio of advancing to declining volumes was 1 to 1.09.

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.56) is normal, around the industry mean (4.25). P/E Ratio (19.15) is within average values for comparable stocks, (75.74). Projected Growth (PEG Ratio) (17.15) is also within normal values, averaging (5.27). GILD's Dividend Yield (3.88) is considerably higher than the industry average of (0.07). P/S Ratio (4.38) is also within normal values, averaging (998.88).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GILD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GILD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

 

 

Related Ticker: GILD

GILD in downward trend: price dove below 50-day moving average on January 26, 2024

GILD moved below its 50-day moving average on January 26, 2024 date and that indicates a change from an upward trend to a downward trend. In of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 22, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on GILD as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for GILD crossed bearishly below the 50-day moving average on February 01, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GILD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GILD entered a downward trend on February 28, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GILD's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where GILD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GILD just turned positive on February 26, 2024. Looking at past instances where GILD's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

GILD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.967) is normal, around the industry mean (5.744). P/E Ratio (16.153) is within average values for comparable stocks, (53.255). Projected Growth (PEG Ratio) (0.414) is also within normal values, averaging (3.094). Dividend Yield (0.041) settles around the average of (0.028) among similar stocks. P/S Ratio (3.373) is also within normal values, averaging (3.808).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GILD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 85.73B. The market cap for tickers in the group ranges from 72.83K to 719.88B. LLY holds the highest valuation in this group at 719.88B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -3%. SCLX experienced the highest price growth at 37%, while MIRA experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -53%. For the same stocks of the Industry, the average monthly volume growth was -68% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 29
P/E Growth Rating: 57
Price Growth Rating: 50
SMR Rating: 58
Profit Risk Rating: 69
Seasonality Score: -35 (-100 ... +100)
Related Portfolios: BIOTECHNOLOGY SECTOR
View a ticker or compare two or three
GILDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
17000
Web
https://www.gilead.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAL42.020.04
+0.10%
Delta Air Lines
AVAV126.61-0.24
-0.19%
AeroVironment
CHSN1.57-0.03
-1.87%
Chanson International Holding
CZFS45.56-1.18
-2.52%
Citizens Financial Services
LC8.03-0.27
-3.25%
LendingClub Corp

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.42%
AMGN - GILD
46%
Loosely correlated
-0.37%
BMY - GILD
36%
Loosely correlated
+0.83%
BIIB - GILD
32%
Poorly correlated
-1.00%
MRK - GILD
32%
Poorly correlated
-0.63%
JNJ - GILD
32%
Poorly correlated
+0.38%
More
Ad is loading...
Yesterday, stock indices posted a growth of approximately 1.5%, potentially forming a reversal pattern. Leading this growth were shares of mineral extraction companies, which saw an average increase of 2-3%. You can check out signals for these company stocks in our robot:Swing-Trader-1-5K-per-position-Hedge-Fund-Style-Trading-TA-FA
The goods industry primarily encompasses producers and sellers of meat, fish, and dairy products. Many companies in this sector also delve into processed food sales. Key players in this domain include Tyson Foods, Inc., Sanderson Farms, and Hormel Foods.
#investment
The "Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)" AI trading robots have emerged as frontrunners in this landscape, showcasing their prowess by achieving a remarkable +7.04% gain through trading AVGO over the past week. This surge in profitability highlights the potential of AI-driven trading bots to outperform traditional methods.
In the ever-evolving landscape of the stock market, the Alternative Power Generation Sector has captured investors' attention with an impressive increase of +8.76% in its performance over the past week. This sector encompasses a diverse group of companies that are striving to reshape the energy industry by harnessing innovative technologies and sustainable solutions. Let's delve into the noteworthy elements of this sector and analyze the group of tickers that define its current trajectory.
This AI Robot is built exclusively for day traders who embrace the art of manual trading and prioritize independent signal selection. With a track record of consistent trading predictions, it empowers traders to make informed choices that align with their individual preferences.
Master swing trading in trending markets with our beginner-focused guides. Achieve +61% annualized returns when markets trend down, and +48% when they rise. Dive into the robotic theme, seeing a 1-week change of +2.91%. Featured stocks: $CGNX, $IRBT, $ISRG, $ROK, $ZBRA. Start trading smartly now!
#artificial_intelligence#up_greenish#trading#technical_analysis
Discover swing trading for beginners, focused on markets trending upward with both TA&FA. After a +0.63% 3-day boost in MU, historical data shows a promising future: in 210 out of 302 instances, MU's price climbed within the next month. With a 70% probability of sustained growth, now's the time to consider MU.
#artificial_intelligence#up_greenish#trading#technical_analysis
One such example is the "Swing trader: Deep Trend Analysis v.2 (TA)" AI trading bot, which has recently showcased its prowess by generating a remarkable +6.27% gain while trading RIVN over the course of the previous week. In this article, we delve into the details of this achievement and analyze the potential impact of the prevailing bearish signals on RIVN's performance.
The Building Products industry has recently surged with an impressive performance increase of +7.71% over the past month. This article delves into the dynamics of this sector, spotlighting its notable tickers and analyzing key trends.
Dive into the dynamic world of insurance agency stocks with our latest blog post! 🚀 Witness the remarkable 18.35% gain that has sent stocks like $AON, $EBIX, $GSHD, $MMC, and $AJG soaring in the insurance sector over the past 6 months. Discover the strategic insights behind this impressive growth and understand how these changes have shaped the industry landscape. From market cap dynamics to high and low price fluctuations, volume trends, and fundamental analysis ratings, we've got you covered. Uncover the factors driving this surge and gain valuable insights into the strategies that could potentially lead to further success. Whether you're a seasoned investor or new to the market, this blog will provide you with an expert analysis of these insurance agency stocks and their potential for continued growth. Don't miss out on the excitement – read now to stay ahead of the investment game! 📊📈
#latest#artificial_intelligence#neutral_bluish#technical_analysis#asset_allocation#trading
Attention traders! Data Storage (DTST) is on a significant uptrend. In just a week, DTST stock has surged by an eye-catching 13.79%. With its recent positive shift in the MACD histogram and an earnings report beating market expectations, this stock is showing strong bullish indicators. In an industry dominated by tech giants, DTST's promising performance stands out. If you're looking for potential growth opportunities in the Information Technology Services Industry, DTST might be worth your attention. Dive into our in-depth analysis to understand why DTST could be the next stock to add to your portfolio.
#latest#popular#patterns#artificial_intelligence#neutral_bluish#technical_analysis#trading
In the dynamic realm of the contract drilling industry, recent market shifts have left their mark on notable players. Transocean Ltd ($RIG), Diamond Offshore Drilling ($DO), Patterson-UTI Energy ($PTEN), Noble ($NE), and PDS Energy ($PDS) find themselves facing collective losses, shedding light on the industry's evolving landscape. As this group grapples with a -4.22% downturn in the past week, our exploration delves into the intricacies of their market capitalizations, high and low price fluctuations, volume trends, and fundamental analysis ratings. Discover how these significant tickers are navigating challenges and learn how market dynamics are shaping their trajectories. Join us as we uncover insights from the contract drilling sector and gain a deeper understanding of the forces at play in this ever-changing market.
#latest#popular#artificial_intelligence#trading#technical_analysis
🚨 Market Alert! 🚨 Stay tuned for more updates, and as always, invest wisely! 💡 In a week marked by notable shifts, Target (TGT, $121.79) experienced a significant downturn, plummeting by -7.18%. But what's causing this dip amidst the broader Discount Stores Industry landscape? Of the 16 monitored stocks from 8/18/2023 to 8/25/2023, a staggering 88.89% were on a downtrend. However, it's not all gloom for Target. Their recent earnings report showcased an EPS of $1.80, surpassing the forecasted $1.47. Additionally, dividend enthusiasts have a silver lining with a forthcoming dividend of $1.10 per share. As giants like Walmart and Costco continue to dominate the market, where does Target's recent performance fit within the bigger picture of discount retailers? Dive deep into our comprehensive analysis to gain insights into Target's current position, industry trends, and what this could mean for future investments. 📊🔍🛍️
#latest#popular#artificial_intelligence#trading#technical_analysis
The 'fish' category primarily encompasses sellers of fish. Many companies within this sector also venture into the production and sale of poultry, frozen meat, and even dairy products. Notable entities in this domain include Lifeway Foods, Inc., Sanderson Farms, Inc., and Hormel Foods Corp.
#artificial_intelligence#investment
The recent performance of the Trend Trader's Popular Stocks: Price Action Trading Strategy (TA&FA) robots has caught the attention of market enthusiasts. These automated trading bots, often referred to as "bot factories," have demonstrated their prowess by generating a notable gain of +5.81% while trading AMTX over the course of the previous week. This achievement becomes even more intriguing when considering the downward trend that AMTX has been experiencing recently.
We're pleased to introduce the Best Robot of the Week by Tickeron—a remarkable achievement in the realm of trading. This week, our robot has once again outperformed the S&P 500 index. Additionally, over the past month, it has outperformed the index for three out of four weeks. This pattern reinforces the dependability and stability of the signals, aligning perfectly with Tickeron's quant team objectives.
The Electronics Distributors industry has recently showcased a remarkable performance surge of +6.01% over the past month, signifying a period of growth and potential for investors. This article delves into the positive outlook and potential opportunities within this dynamic industry, focusing on key tickers and indicators that underscore its current trajectory.
The Dow and S&P have both declined by 3.4% and 4%, respectively, since the beginning of the month, while the Nasdaq has experienced a loss of approximately 5.3%. The airline industry stocks have been hit the hardest, with some stocks seeing declines of over 20%. Signals for these stocks can be obtained by subscribing to one of our robots Swing-Trader-700-per-position-Hedge-Fund-Style-Trading-TA-FA.
The Metabolic Sector Biotechnology companies that produce drugs to treat gastrointestinal and metabolism disorders are classified under the 'metabolic' category. These disorders often encompass obesity, which can potentially lead to severe diseases such as cardiovascular ones
#artificial_intelligence#investment
Discover the impressive 6.17% gain within the Human Capital sector as we delve into the performance of key tickers like $PAYC, $RHI, $EFX, $PRFT, and $AMN. Uncover market insights, potential trends, and the factors driving this substantial growth in the dynamic world of human resources and staffing solutions.